Zobrazeno 1 - 10
of 85
pro vyhledávání: '"J. Macé-Lesec'h"'
Autor:
F. Ménégoz, E. Martin, A. Danzon, H. Mathieu-Daudé, A.-V. Guizard, J. Macé-Lesec’h, N. Raverdy, B. Pasquier, M. Colonna
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 54:399-406
Position du probleme L’incidence du cancer est mesuree en France par les registres des cancers qui ne couvrent que 13,5 a 16 % de la population francaise. Les donnes nationales sont donc necessairement basees sur des estimations. Des disparites d
Autor:
J.E. Couette, J.F. Héron, Michel Henry-Amar, Florence Joly, P. Bottet, N. Allouache, D. Brune, J. Macé-Lesec’h, L. Kalusinski, J. Pény
Publikováno v:
Journal of Clinical Oncology. 20:73-80
PURPOSE: To evaluate quality of life and social problems in long-term survivors of testicular cancer. PATIENTS AND METHODS: In 1998, 71 testicular cancer survivors (cases) identified from the Calvados General Tumor Registry were enrolled onto a case-
Autor:
B. Vie, A. Tanguy, A. Busson, Michel Leporrier, Pierre Lebailly, J. Macé-Lesec’h, A. M. Peny, Xavier Troussard, Oumedaly Reman, Florence Joly, Michel Henry-Amar, J Y Génot, Patrick Arveux
Publikováno v:
Journal of Clinical Oncology. 14:2444-2453
PURPOSE To evaluate late psychosocial sequelae in long-term survivors of Hodgkin's disease (HD) in the population of Calvados, France. PATIENTS AND METHODS Ninety-three patients issued from the Calvados General Tumor Registry, treated from 1978 to 19
Autor:
Xavier Sastre, V Le Doussal, P. Terrier, Françoise Bonichon, Nguyen Binh Bui, C Barlier, Michel Henry-Amar, H Duplay, Jocelyne Jacquemier, J. Macé-Lesec’h, Geneviève Contesso, Marie-Odile Vilain, F. Collin, Jean Michel Coindre, A. M. Mandard
Publikováno v:
Journal of Clinical Oncology. 14:869-877
PURPOSE To define the prognostic factors in adult patients with locally controlled soft tissue sarcoma (STS) and to determine which patients should be considered for adjuvant treatment. PATIENTS AND METHODS Five hundred forty-six patients with a nonm
Autor:
E, Bauvin, M, Soulié, F, Ménégoz, J, Macé-Lesec'h, A, Buémi, M, Velten, A, Villers, P, Grosclaude
Publikováno v:
European journal of cancer (Oxford, England : 1990). 39(16)
Non-medical factors influencing treatment choices in prostate cancer are not well understood. We carried out a population-based study to obtain information on the management of prostate cancer patients. Our study population consisted of 1000 men diag
Autor:
T, Delozier, M, Spielmann, J, Macé-Lesec'h, M, Janvier, C, Hill, B, Asselain, J P, Julien, B, Weber, L, Mauriac, J C, Petit, P, Kerbrat, J P, Malhaire, P, Vennin, B, Leduc, M, Namer
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 18(20)
In 1986, The Fédération Nationale desCentres de Lutte Contre le Cancer Breast Group initiated a multicenter randomized trial to assess the usefulness of long-term adjuvant tamoxifen treatment. Short-term adjuvant tamoxifen treatment was to be compa
Autor:
J. Macé-Lesec'h, D. Lebrun-Jezekova, P. Chinet-Charrot, J.F. Héron, P. Kerbrat, Florence Joly, H. Crouet, Catherine Lhommé, D. Vennin, M. Rios, J. Chauvergne, A. Goupil, F. Mayer
Publikováno v:
Gynecologic oncology. 78(3 Pt 1)
The aim of this study was to evaluate the impact of platinum dose intensity on pathological response rate and overall survival in patients with advanced ovarian adenocarcinoma.Between February 1992 and December 1996, 195 previously untreated patients
Autor:
J J, Michels, J P, Rame, D, de Raucourt, J, Marnay, F, Duigou, J, Macé-Lesec'h, M, Henry-Amar, A M, Mandard
Publikováno v:
Bulletin du cancer. 84(7)
The possibility to perform flow cytometry was examined in a series of 167 patients with primary untreated head and neck carcinoma referred to our Institution from February 1989 to January 1992. In all cases, flow cytometry was carried out on frozen t
Autor:
T, Delozier, O, Switsers, J Y, Génot, J M, Ollivier, M, Héry, M, Namer, M, Frenay, P, Kerbrat, J P, Julien, A, Naja, M, Janvier, J, Macé-Lesec'h
Publikováno v:
Bulletin du cancer. 84(1)
Adjuvant tamoxifen (TAM) has been proved to reduce recurrence and mortality in early breast cancer, nevertheless many patients did not receive TAM as adjuvant therapy after local treatment. In order to study the efficacy of delayed TAM therapy in pat
Autor:
J.P. Julien, J. Macé-Lesec’h, Bernard Asselain, P. Kerbrat, M. Spielmann, L. Mauriac, B. Weber, J.C. Petit, Thierry Delozier, Maud Janvier
Publikováno v:
European Journal of Cancer. 33:S80